Regulation of cellular functions by chaperone-like AAA-ATPases, VCP and NVL
Regulation of cellular functions by chaperone-like AAA-ATPases, VCP and NVL
批准号:
15570166
负责人:
NAGAHAMA Masami
金额:
$2.37万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004
中文摘要
VCP是一种aaa - atp酶,在细胞功能如内质网相关降解(ERAD)和细胞器生物发生中起关键作用。SVIP是一种与vcp相互作用的蛋白,其表达通过内质网扩增引起细胞空泡形成。为了阐明SVIP的细胞功能,我们首先通过体内和体外实验研究了SVIP在ERAD中的作用。两种分析的结果都表明,额外的SVIP抑制ERAD,这可能是内质网空泡化的原因。接下来,为了鉴定VCP-SVIP复合物中涉及的其他蛋白质成分,我们以整个SVIP为诱饵进行酵母双杂交筛选,结果获得了几个编码SVIP相关蛋白的cdna。NVL2是一种与VCP氨基酸相似性较高的蛋白。与VCP的主要细胞质分布相反,NVL2的定位仅限于核核,表明NVL2在该核亚室中的特殊作用。在这项研究中,我们发现NVL2与RNA解旋酶相互作用,并参与60S核糖体的生物发生。尽管nnvl2的显性阴性突变体的表达不影响rRNA加工,但它导致解旋酶在一个大复合体中积累,可能是核糖体前颗粒。此外,诱变研究在NVL2中发现了核仁定位信号。该信号是NVL2与核糖体蛋白L5结合所必需的,这表明NVL2是通过与L5结合而被招募到核仁的。
英文摘要
VCP is an AAA-ATPase, which plays critical roles for cellular functions such as endoplasmic reticulum associated degradation(ERAD) and organella biogenesis. SVIP has been identified as a VCP-interacting protein, whose expression causes cell vacuolation by expansion of ER. To clarify a cellular function of SVIP, we first investigated a role of SVIP for ERAD by employing assays in virto and in vivo. The results from both the assays showed that extra amount of SVIP inhibits ERAD and this may be a cause of the ER vacuolation. Next, to identify other protein components involved in the VCP-SVIP complex, yeast two-hybrid screening was performed using entire SVIP as a bait As a result, several cDNAs encoding putative SVIP-associated proteins were obtained.NVL2 is a protein that shows high amino acid similarity with VCP. In contrast to mainly cytosolic distribution of VCP, localization of NVL2 is restricted to the nucleolus, suggesting a specialized role of NVL2 in this nuclear subcompartment. In this research, we showed that NVL2 interacts with a RNA helicase and is involved in biogenesis of 60S ribosomes. Although expression of a dominant-negative mutant of NVL2 did not affect rRNA processing, it caused accumulation of the helicase in a large complex, probably a pre-ribosomal particle. Additionally, mutagenesis studies identified a nucleolar localization signal in NVL2. This signal is required for the binding of NVL2 with ribosomal protein L5,suggesting that NVL2 is recruited to the nucleolus by associating with L5.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1091/mbc.e04-08-0692
发表时间:
2004-10
期刊:
Molecular biology of the cell
影响因子:
3.3
作者:
[M. Nagahama;Y. Hara;Akihiro Seki;Takeshi Yamazoe;Yumiko Kawate;T. Shinohara;K. Hatsuzawa;K. Tani-K.]
通讯作者:
M. Nagahama;Y. Hara;Akihiro Seki;Takeshi Yamazoe;Yumiko Kawate;T. Shinohara;K. Hatsuzawa;K. Tani-K.
Studies on a novel protein complex involved in RNA metabolism during ribosome biogenesis and its regulation by a molecular chaperone
-
批准号:24590101
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2012
-
负责人:NAGAHAMA Masami
-
依托单位:
Regulatory mechanism of the ribosomal RNA processing complex by AAA-ATPase NVL2
-
批准号:19570180
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2007
-
负责人:NAGAHAMA Masami
-
依托单位:
Functional of nucleolar AAA-ATPase NVL2 in ribosome biogenesis.
-
批准号:17570165
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2005
-
负责人:NAGAHAMA Masami
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ERAD/ER-phagy双途径调控GPX4降解介导砷致神经元铁死亡的分子机制
-
批准号:82560632
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:阳益萍
-
依托单位:
NAAA通过调控ERAD通路抑制HBV复制的作用及机制研究
-
批准号:82560391
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:张勇
-
依托单位:
C19ORF18通过抑制SEL1L-HRD1 ERAD功能
激活IRE1α在肝脏脂代谢紊乱中的作用
及机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2025
-
负责人:高荣
-
依托单位:
ERAD组分OsUBC45与效应蛋白互作调控水稻免疫的机制研究
-
批准号:32502442
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:王羽
-
依托单位:
METTL1/WDR4 通过m7G调控FAM8A1促进ERAD诱导的巨噬细胞极化改善慢阻肺的机制研究
-
批准号:82560005
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2025
-
负责人:张雅囡
-
依托单位:
葛根芩连汤可变调控IRE1α-XBP1s应对内质网应激诱导UPR/ERAD/自噬/凋亡的动态传变延缓T2DM发生发展的机制研究
-
批准号:82460859
-
项目类别:地区科学基金项目
-
资助金额:32.00万元
-
批准年份:2024
-
负责人:涂珺
-
依托单位:
去泛素化酶OTUD5在内质网相关蛋白降解(ERAD)中作用的研究
-
批准号:32371313
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:赵文会
-
依托单位:
基于“正虚伏毒”探究外泌体miRNA-UPR-ERAD/ERSIA通路对肺癌恶病质作用及中药干预研究
-
批准号:2023JJ40486
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:孙银辉
-
依托单位:
EMC6/ERAD调控肌质网稳态改善心肌肥厚的作用机制
-
批准号:32371242
-
项目类别:面上项目
-
资助金额:50万元
-
批准年份:2023
-
负责人:郑铭
-
依托单位:
基于Sel1L探讨ERAD在泌乳调节中的作用与机制
-
批准号:82301824
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:刘力
-
依托单位: